Jci_page_head_homepage_01 Jci_page_head_homepage_02
Timothy A. McCaffrey, Chenzhong Fu, Baoheng Du, Sukru Eksinar, K. Craig Kent, Harry Bush, Karl Kreiger, Todd Rosengart, Myron I. Cybulsky, Eric S. Silverman, Tucker Collins
Published in Volume 105, Issue 5
J Clin Invest. 2000; 105(5):653–662 doi:10.1172/JCI8592
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 4

Immunochemical identification of Egr-1 in human atherosclerotic carotid arteries and IMA. Frozen sections of human endarterectomies or IMA were probed with Egr-1–specific antibodies. (a) Atherosclerotic carotid artery lesion stained with anti-Egr-1 antibodies yielding a dark brown reaction product in positive cells. (b) Double-staining reveals strong Egr-1 staining (brown) in lesion cells of the fibrous cap that co-stain with the SMC/myofibroblast marker α-actin (dark blue). Egr-1 staining is also visible in cells that stain only faintly for α-actin. (c) Adjacent tunica media from the same section showing sparse labeling. (d) Egr-1 staining in frozen sections from IMA obtained during bypass grafting. Only a light hematoxylin stain (blue) is visible, whereas Egr-1 staining (brown) is not detected.